Tech Company Financing Transactions

Corthera Funding Round

Domain Associates, Kleiner Perkins Caufield & Byers and Sears Capital Management participated in a $20 million Series C funding round for Corthera. The financing round closed on 11/2/2007.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

FinTech

Mailing Address

1660 S. Amphlett Blvd. 200
San Mateo, CA 94402
USA

Phone

650-235-3555

Website

www.corthera.com

Email Address

[email protected]

Overview

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stan Abel

        

Chief Medical Officer

Sam Teichman

        

Chief Operating Officer

Rick Orr

        

Founder

Dennis Stewart

        

Vice President

Ernst Rinderknecht

        

Vice President

Elaine Unemori

        

Browse more venture capital transactions:

Prev: 11/2/2007: Vapotherm venture capital transaction
Next: 11/2/2007: HemaQuest Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC transactions reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary